18 June 2013
Keywords: dyax, expands, ab, deal, biogen, biotherapeutics, firm
Article | 16 February 2009
Biotherapeutics firm Dyax says it has expanded its antibody funded research and library license agreement with fellow USA-based Biogen Idec
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 February 2009
17 June 2013
© 2013 thepharmaletter.com